Business Wire

Inspur Information Releases 2020 Global Computing Index Report

26.2.2021 11:07:00 EET | Business Wire | Press release

Share

Inspur Information, a leading IT infrastructure solutions provider, has sponsored an International Data Corporation (IDC) white paper on the 2020 Global Computing Index (henceforth referred to as The Report). As the world’s first index report on computing, The Report unveils the relationship between computing power and economic development and serves as a reference for the outlook of the global digital economy.

Global digital transformation has entered a phase marked by exponential growth in innovation, with the size of the digital economy projected to continue on an upward trend. As a key factor that underlies digital technology development, computing is now defining the productivity of the digital economy era. According to The Report, economic growth directly correlates with the development of computing—one point of growth in the computing index translates to a 3.3‰ rise in the size of the digital economy and a 1.8‰ growth in GDP. Specifically, AI computing market share is projected to continue on this upward trajectory. Research on computing markets in sample countries shows that AI computing market share has grown from 7% in 2015 to 12% of the overall computing market in 2019 and is expected to reach 23% in 2024. With the largest number of hyper-scale data centers in the world, the United States has demonstrated its strong infrastructure support for computing power growth, ranking first on the index ranking with a score of 75. In second place with a score of 66 is China, followed by Japan (55), Germany (52), and the United Kingdom (47).

The Global Computing Index represents a year-long joint effort by Inspur Information and IDC. The Report, covering Australia, Brazil, China, France, Germany, Japan, Russia, South Africa, the United Kingdom, and the United States, offers a comprehensive assessment of computing power across four dimensions: computing capacity, computing efficiency, application level, and infrastructure support.

Zhang Dong, vice president of Inspur Information, noted that "the application of emerging technologies, especially AI, will be driving the advancement of computing. As the volume of data and the complexity of algorithms continues to rise, computing will be the determining factor for the AI development ceiling.”

Computing Defines Productivity in the Digital Economy Era; Synchronized Development of Emerging Technology Applications and Computing will Foster Economic Growth

The development of emerging technologies and computing are mutually beneficial in that computing power provides infrastructure support for emerging technologies, which in turn pushes forward the evolution of computing. IoT, AI, and big data are among the major emerging technologies.

In 2020, the global spending on AI by enterprises was forecast to be US$49.87 billion, and this number is estimated to reach US$96.28 billion by 2023. The development of AI is driven by the advancement in computing, data, and algorithms, and sufficient computing power is necessary for the processing of large amounts of data using complex algorithms. The widespread application of IoT will give rise to the fast advancement of edge computing, which has already reshaped IT infrastructure and will revolutionize computing, storage, and networks. Cloud computing is the most important means for improving computing efficiency. IT infrastructure that supports same-pace development of cloud and edge will enable applications of emerging technologies, improve computing power, and eventually reap bigger economic rewards. AI, IoT, cloud computing, and other emerging technologies will be the main drivers for IT spending in the future.

Inspur Empowers Computing Power Upgrade through Investment in Open Computing and Artificial Intelligence

The Report builds a comparative formula between computing power and economic development and serves as a reference for countries to improve their computing power and economic competitiveness. The digital economy is a significant component of GDP and computing is the foundation for the development of the digital economy.

As a leading force in emerging technologies, Inspur is the only server vendor who has joined all major open computing organizations, including OCP (Open Compute Project), ODCC and Open19, and is a Gold Member of OpenStack. Inspur leads the OpenRMC subproject, which focuses on next-generation data center management standards, and is an active member in OAM specification, the Scorpio Project, and the OTII for establishing edge computing standards.

In artificial intelligence, Inspur is the chair of SPEC ML, the Technical Committee on Machine Learning under the international evaluation organization SPEC. While working closely with leading tech companies in AI systems and applications, Inspur leads SPEC ML in the development of AI Test specifications and related benchmarks. As of today, Inspur has the most complete array of GPU servers in the industry with nearly 20 computing platforms supporting GPU numbers ranging from 4 to 64. Inspur also provides ultimate-design GPU servers such as the Inspur NF 5488A5, a 19-time record-setting server in the MLPerf benchmarks. Inspur currently offers full-stack AI capabilities including AI Computing Platform, AI Resource Suite, and Algorithm Toolkit.

Please click for more insights from the report.

About Inspur Information

Inspur Electronic Information Industry Co., LTD is a leading provider of data center infrastructure, cloud computing, and AI solutions, ranking among the world’s top 3 server manufacturers. Through engineering and innovation, Inspur delivers cutting-edge computing hardware design and extensive product offerings to address important technology arenas like open computing, cloud data center, AI and deep learning. Performance-optimized and purpose-built, our world-class solutions empower customers to tackle specific workloads and real-world challenges. To learn more, please go to en.inspur.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Fiona Liu
Inspur Information
liuxuan01@inspur.com

Vivian Dadamio
vivian@allisonpr.com
+49 89 3888 920 10
+49 (0)176 32 666 550

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 13:38:00 EEST | Press release

For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will

Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 12:48:00 EEST | Press release

Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye